APA aipamena

Xing, Z., Li, X., He, Z. N. T., Fang, X., Liang, H., Kuang, C., . . . Yang, Q. (2024). IDO1 Inhibitor RY103 Suppresses Trp-GCN2-Mediated Angiogenesis and Counters Immunosuppression in Glioblastoma. MDPI AG.

Chicago Style aipamena

Xing, Zikang, Xuewen Li, Zhen Ning Tony He, Xin Fang, Heng Liang, Chunxiang Kuang, Aiying Li, and Qing Yang. IDO1 Inhibitor RY103 Suppresses Trp-GCN2-Mediated Angiogenesis and Counters Immunosuppression in Glioblastoma. MDPI AG, 2024.

MLA aipamena

Xing, Zikang, et al. IDO1 Inhibitor RY103 Suppresses Trp-GCN2-Mediated Angiogenesis and Counters Immunosuppression in Glioblastoma. MDPI AG, 2024.